News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
8794
Sources here
13
Companies here
32
Search results Stored financial headlines

Active search

8794 matching headlines

Ticker or company: CALMain company stories
Clear

Citius Pharmaceuticals GAAP EPS of -$0.34 misses by $0.09, revenue of $1.5M misses by $8.27M

* Citius Pharmaceuticals press release [https://seekingalpha.com/pr/20620155-citius-pharmaceuticals-inc-reports-fiscal-third-quarter-2026-financial-results-and-provides] (CTXR [https://seekingalpha.com/symbol/CTXR]): Q3 GAAP EPS of -$0.34 misses by $0.09. * Revenue of $1.5M misses by $8.27M. * Cash and cash equivalents of $17.0 million as of June 30, 2026. MORE ON CITIUS PHARMACEUTICALS * Seeking Alpha’s Quant …

CTXR main company
Sharemaestro market context Price above Trend Line 52 weeks -44.0% · Next-week setup negative 40.1% CTXR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Westlake Corporation declares $0.533 dividend

* Westlake Corporation (WLK [https://seekingalpha.com/symbol/WLK]) declares $0.533/share quarterly dividend [https://seekingalpha.com/pr/20620238-westlake-corporation-declares-quarterly-dividend], 0.6% increase from prior dividend of $0.530. * Forward yield [https://seekingalpha.com/symbol/WLK/dividends/yield?source=news_bullet] 2.68% * Payable Sept. 10; for shareholders of record Aug. 25; ex-div Aug. 25. * See WLK Dividend Scorecard, Yield Chart, & Dividend …

WLK main company
Sharemaestro market context Price below Trend Line 52 weeks -10.5% WLK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Why Did ICL Group (ICL) Move Today?

ICL Group (NYSE:ICL) recently reported Q2 2026 sales of US$2,135 million and net income of US$137 million, alongside approving a new operating model. This news has led to a 9.90% share price increase over 30 days, although the stock is still down over longer …

ICL main company
Sharemaestro market context Price above Trend Line 52 weeks -9.6% ICL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vanda Prepares BYSANTI Launch As Patent Protection Extends To 2044

Vanda Pharmaceuticals is set to launch BYSANTI in the second half of 2026 following FDA approval for bipolar I disorder and schizophrenia, with patent protection extending until May 2044. The company also reported strong Q2 Fanapt sales growth and has several late-stage pipeline readouts …

VNDA main company
Sharemaestro market context Price below Trend Line 52 weeks +9.9% VNDA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Oppenheimer Just Upgraded Intuitive Surgical Stock. Here's Why.

Intuitive Surgical Inc location sign-by Sundry Photography via iStock Analysts at Oppenheimer recently upgraded the medtech company Intuitive Surgical (ISRG) from "Perform" to "Outperform" and set a $500 price target, implying a 24.6% upside from current levels. Expecting the company to benefit from the …

ISRG main company I1SR34 main company IUI1 main company ISRG19 main company
Sharemaestro market context Price below Trend Line 52 weeks -23.4% ISRG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

STAAR Surgical (STAA) Gives Warren Foust The CEO Role After Its Profit Reset

STAAR Surgical has appointed Warren Foust as its permanent President and CEO, following a period of operational reset and a return to profitable growth under his interim leadership. Foust's promotion from COO and interim co-CEO signifies a defined leadership direction for the ophthalmic device …

STAA main company
Sharemaestro market context Trend signal active 52 weeks -6.0% · Next-week setup negative 40.7% STAA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Why Tarsus Pharmaceuticals (TARS) Is Up 6.8% After Raising XDEMVY 2026 Sales Guidance - And What's Next

Tarsus Pharmaceuticals (TARS) saw its stock rise by 6.8% after reporting strong second-quarter 2026 results and raising its 2026 XDEMVY net product sales guidance to US$685 million–US$705 million. This increase signals management's confidence in XDEMVY's commercial trajectory, though the company still faces risks associated …

TARS main company
Sharemaestro market context Price above Trend Line 52 weeks +20.9% · Next-week setup positive 62.0% TARS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Westlake Corporation Stock (WLK) Opinions on Dividend Hike and Profitability Turnaround

Westlake Corporation (WLK) recently increased its quarterly dividend to 53.3 cents, signaling steady cash generation and operational discipline. The company has returned to profitability due to improved pricing power and cost reductions, sparking interest in its valuation. While some technical views indicate near-term underperformance, …

WLK main company
Sharemaestro market context Price below Trend Line 52 weeks -10.5% WLK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

94,594 Shares in Air Products and Chemicals, Inc. $APD Purchased by S&CO Inc.

S&CO Inc. has acquired 94,594 shares of Air Products and Chemicals (NYSE:APD) for approximately $27.7 million, making it their 17th largest holding. The company recently reported strong quarterly earnings, beating analyst estimates with an EPS of $3.47 and a 4.6% year-over-year revenue increase. Analysts …

APD main company
Sharemaestro market context Trend signal active 52 weeks +5.3% APD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

S&CO Inc. Acquires New Holdings in Intuitive Surgical, Inc. $ISRG

S&CO Inc. has acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by purchasing 5,121 shares valued at approximately $2.04 million in the second quarter. This move comes as Intuitive Surgical reported strong quarterly results, exceeding analyst estimates with earnings of $2.80 per share …

ISRG main company
Sharemaestro market context Price below Trend Line 52 weeks -17.1% · Next-week setup negative 41.3% ISRG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

What Westlake (WLK)'s Return To Profitability And Ongoing Dividend Growth Means For Shareholders

Westlake Corporation reported a return to profitability in Q2 2026 with sales of US$3,271 million and net income of US$260 million, a significant improvement from a net loss in the prior year. This, coupled with 22 years of dividend increases, suggests a strong commitment …

WLK main company
Sharemaestro market context Price below Trend Line 52 weeks -10.5% WLK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BioMarin Pharmaceutical (BMRN) Updates Guidance And Files Shelf Registration, Is It Still Below Fair Value?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. BioMarin Pharmaceutical (BMRN) has just given investors a packed update, including second quarter 2026 results, fresh earnings guidance for the rest of the …

BMRN main company B1MR34 main company BMRN main company BMRN main company
Sharemaestro market context New activity signal 52 weeks +11.9% · Next-week setup negative 4.6% BMRN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

USA Financial Formulas Acquires New Position in Regeneron Pharmaceuticals, Inc. $REGN

USA Financial Formulas has acquired a new stake in Regeneron Pharmaceuticals (NASDAQ:REGN), purchasing 1,457 shares valued at approximately $1.13 million, making it their 27th-largest portfolio holding. Institutional investors collectively own 83.31% of Regeneron, with several major firms significantly increasing their positions. The company recently …

REGN main company
Sharemaestro market context Price above Trend Line 52 weeks +36.8% REGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Quantinno Capital Management LP Takes $1.11 Million Position in STAAR Surgical Company $STAA

Quantinno Capital Management LP has acquired a new position in STAAR Surgical Company, purchasing 59,302 shares valued at approximately $1.11 million. This makes Quantinno Capital Management LP a 0.12% stakeholder in the company, which has seen its revenue increase by 111.1% year-over-year in the …

STAA main company
Sharemaestro market context Trend signal active 52 weeks -6.0% · Next-week setup negative 40.7% STAA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ICU Medical, Inc. (NASDAQ:ICUI) Given Average Rating of "Moderate Buy" by Brokerages

ICU Medical, Inc. (NASDAQ:ICUI) has received a "Moderate Buy" consensus rating from nine analysts, with an average 12-month price target of $192.80. The company recently surpassed quarterly earnings and revenue expectations, reporting $2.37 EPS on $547.88 million in revenue, and provided fiscal 2026 EPS …

ICUI main company
Sharemaestro market context Trend signal active 52 weeks +42.8% ICUI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ionis (IONS) Stock Looks Like A Bargain On Value But Full On Sales

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Ionis Pharmaceuticals stock carries a strong three year return record alongside a high overall value score, yet current market multiples still point to the shares …

IONS main company
Sharemaestro market context Price below Trend Line 52 weeks +34.1% · Next-week setup positive 55.1% IONS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Empowered Funds LLC Buys 16,525 Shares of Alpha Metallurgical Resources, Inc. $AMR

Empowered Funds LLC increased its stake in Alpha Metallurgical Resources, Inc. (NYSE:AMR) by 79.4% in the first quarter, adding 16,525 shares and bringing its total holdings to 37,347 shares valued at approximately $7.7 million. Other institutional investors also adjusted their positions in AMR, which …

AMR main company
Sharemaestro market context Price below Trend Line 52 weeks +17.4% · Next-week setup negative 39.3% AMR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context